(Q35009519)

5 August 2017

1 reference

title

Review article: breath testing for human liver function assessment (English)

1 reference

5 August 2017

1 reference

Armuzzi A

1

1 reference

5 August 2017

Candelli M

2

1 reference

5 August 2017

Zocco MA

3

1 reference

5 August 2017

Andreoli A

4

1 reference

5 August 2017

De Lorenzo A

5

1 reference

5 August 2017

Nista EC

6

1 reference

5 August 2017

Miele L

7

1 reference

5 August 2017

Cremonini F

8

1 reference

5 August 2017

Cazzato IA

9

1 reference

5 August 2017

Grieco A

10

1 reference

5 August 2017

Gasbarrini G

11

1 reference

5 August 2017

Gasbarrini A

12

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Alimentary Pharmacology & Therapeutics

5 August 2017

1 reference

5 August 2017

16

1 reference

5 August 2017

12

1 reference

5 August 2017

1977-1996

1 reference

The [14C]-aminopyrine breath test. A comparison of different forms of analysis

5 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Influence of low-dose oral contraceptives, alcohol, and grapefruit on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Aminopyrine demethylation measured by breath analysis in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Unaltered drug metabolizing enzyme systems in type II diabetes mellitus before and during glyburide therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Lack of inhibitory effect of cimetidine on caffeine metabolism in children using the caffeine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

The erythromycin breath test as a predictor of cyclosporine blood levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Tyrosine Metabolism in Patients with Liver Disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Optimum conditions for the 13C-phenylalanine breath test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Evaluation of 13C-phenylalanine and 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Hepatic phenylalanine metabolism measured by the [13C]phenylalanine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Alterations in mitochondrial function and morphology in chronic liver disease: pathogenesis and potential for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Ethanol metabolism, cirrhosis and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

S-adenosylmethionine synthesis: molecular mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Methionine metabolism in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Acute valproate-associated microvesicular steatosis: could the [13C]methionine breath test be useful to assess liver mitochondrial function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

THE GALACTOSE ELIMINATION CAPACITY IN CONTROL SUBJECTS AND IN PATIENTS WITH CIRRHOSIS OF THE LIVER

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Aminopyrine metabolism in the presence of hyperbilirubinemia due to cholestasis or hepatocellular disease. Combined use of laboratory tests to study disease-induced alterations in drug disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

The aminopyrine breath test for the evaluation of liver function in alcoholic patients: drug pharmacokinetics and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Validation of 13CO2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Studies on 13C-phenacetin metabolism. II. A combination of breath test and urine test of in vivo metabolites in the diagnosis of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Effects of dietary protein on theophylline pharmacokinetics and caffeine and aminopyrine breath tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Erythromycin breath test and clinical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

[13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Abnormal phenylalanine hydroxylation and tyrosine oxidation in a patient with acute fulminant liver disease with correction by liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Determination of (13)CO(2)/(12)CO(2) Ratio by IRMS and NDIRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

Metabolic abnormalities associated with postoperative organ failure. A redox theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01374.X

10.1046/J.1365-2036.2002.01374.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference